Effect of Urinary Albumin Creatinine Ratio on Cardiovascular Morbidity and Mortality in Diabetes Patients with Atherosclerotic Disease

References

• Gerstein HC, Mann JF, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286(4):421–426. doi:10.1001/jama.286.4.421
   PubMed Web of Science ®Google Scholar
• Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D’Agostino RB. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 2008;31(8):1582–1584. doi:10.2337/dc08-0025
   PubMed Web of Science ®Google Scholar
• Mosenzon O, Alguwaihes A, Leon JLA, et al. CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries. Cardiovasc Diabetol. 2021;20(1):154. doi:10.1186/s12933-021-01344-0
   PubMed Web of Science ®Google Scholar
• Iglay K, Hannachi H, Engel SS, et al. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis. Curr Med Res Opin. 2021;37(5):743–751. doi:10.1080/03007995.2021.1895736
   PubMed Web of Science ®Google Scholar
• Muzurović EM, Re: BS, Iglay K, et al. Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysis. Curr Med Res Opin. 2021;37(8):1293–1294. doi:10.1080/03007995.2021.1920381
   PubMed Web of Science ®Google Scholar
• Deckert T, Kofoed-Enevoldsen A, Nørgaard K, Borch-Johnsen K, Feldt-Rasmussen B, Microalbuminuria JT. Implications for micro- and macrovascular disease. Diabetes Care. 1992;15(9):1181–1191. doi:10.2337/diacare.15.9.1181
   PubMed Web of Science ®Google Scholar
• Czekalski S. [What is new in the treatment of diabetes?--The importance of nephro- and cardioprotective management]. Pol Arch Med Wewn. 2004;112:65–69. Polish
   PubMedGoogle Scholar
• Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• ElSayed NA, Aleppo G, Aroda VR, et al. 10. Cardiovascular disease and risk management: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl1):S158–s90. doi:10.2337/dc23-S010
   PubMedGoogle Scholar
• Forbes A, Gallagher H. Chronic kidney disease in adults: assessment and management. Clin Med. 2020;20(2):128–132. doi:10.7861/clinmed.cg.20.2
   PubMed Web of Science ®Google Scholar
• Willison A, Tully V, Davey P. All patients with diabetes should have annual UACR tests. Why is that so hard? BMJ Qual Improv Rep. 2016;5(1):u209185.w3747. doi:10.1136/bmjquality.u209185.w3747
   PubMedGoogle Scholar
• Cao JJ, Biggs ML, Barzilay J, et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: the Cardiovascular Health Study. Atherosclerosis. 2008;197(2):806–813. doi:10.1016/j.atherosclerosis.2007.07.029
   PubMed Web of Science ®Google Scholar
• Chen SQ, Liu J, Zhou Y, et al. Sex differences in characteristics, treatments, and in-hospital outcomes of patients undergoing coronary angiography or intervention. Front Cardiovasc Med. 2022;9:878566. doi:10.3389/fcvm.2022.878566
   PubMed Web of Science ®Google Scholar
• Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ. Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction. JACC Heart Fail. 2014;2(6):586–596. doi:10.1016/j.jchf.2014.05.016
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S1–45. doi:10.1161/01.cir.0000437738.63853.7a
   PubMed Web of Science ®Google Scholar
• Aguiar-Souto P, Ferrante G, Del Furia F, Barlis P, Khurana R, Di Mario C. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol. 2010;139(1):68–74. doi:10.1016/j.ijcard.2008.10.006
   PubMed Web of Science ®Google Scholar
• Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5–37.
   PubMedGoogle Scholar
• Docherty KF, Curtain JP, Anand IS, et al. Effect of dapagliflozin on anaemia in DAPA-HF. Eur J Heart Fail. 2021;23(4):617–628. doi:10.1002/ejhf.2132
   PubMed Web of Science ®Google Scholar
• Bansal N, Zelnick LR, Alonso A, et al. eGFR and albuminuria in relation to risk of incident atrial fibrillation: a meta-analysis of the Jackson heart study, the multi-ethnic study of atherosclerosis, and the cardiovascular health study. Clin J Am Soc Nephrol. 2017;12(9):1386–1398. doi:10.2215/CJN.01860217
   PubMed Web of Science ®Google Scholar
• Kang M, Kwon S, Lee J, et al. Albuminuria within the normal range can predict all-cause mortality and cardiovascular mortality. Kidney. 2022;3(1):74–82. doi:10.34067/KID.0003912021
   Google Scholar
• Liu S, Niu J, Wu S, et al. Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths: a prospective analysis. BMJ Open. 2021;11(3):e040890. doi:10.1136/bmjopen-2020-040890
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang J, Zhao J, Zhang L. Association between body mass index combined with albumin: creatinine ratio and all-cause mortality in Chinese population. Sci Rep. 2017;7(1):10878. doi:10.1038/s41598-017-11084-5
   PubMedGoogle Scholar
• Anyanwagu U, Donnelly R, Individual II. Combined relationship between reduced eGFR and/or increased urinary albumin excretion rate with mortality risk among insulin-treated patients with type 2 diabetes in routine practice. Kidney Dis. 2019;5(2):91–99. doi:10.1159/000493731
   Google Scholar
• Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: improving Global Outcomes (KDIGO) staging. BMC Res Notes. 2014;7:415. doi:10.1186/1756-0500-7-415
   PubMedGoogle Scholar
• Triposkiadis F, Xanthopoulos A, Bargiota A, et al. Diabetes mellitus and heart failure. J Clin Med. 2021;10:16. doi:10.3390/jcm10163682
   Google Scholar
• Gutterman DD. Vascular dysfunction in hyperglycemia: is protein kinase C the culprit? Circ Res. 2002;90(1):5–7. doi:10.1161/res.90.1.5
   PubMed Web of Science ®Google Scholar
• Perticone F, Maio R, Tripepi G, Zoccali C. Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation. 2004;110(7):821–825. doi:10.1161/01.CIR.0000138745.21879.27
   PubMed Web of Science ®Google Scholar
• Perticone F, Maio R, Perticone M, et al. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation. 2010;122(4):379–384. doi:10.1161/CIRCULATIONAHA.110.940932
   PubMed Web of Science ®Google Scholar
• Jia X, Al Rifai M, Birnbaum Y, Smith SC, Virani SS. The 2018 cholesterol management guidelines: topics in secondary ASCVD prevention clinicians need to know. Curr Atheroscler Rep. 2019;21(6):20. doi:10.1007/s11883-019-0784-8
   PubMed Web of Science ®Google Scholar
• Deveci OS, Kabakci G, Tulumen E, et al. The relationship between microalbuminuria and the presence and extent of coronary atherosclerosis. Angiology. 2010;61(2):184–191. doi:10.1177/0003319709340892
   PubMed Web of Science ®Google Scholar
• Hoseini VN, Rasouli M. Microalbuminuria correlates with the prevalence and severity of coronary artery disease in non-diabetic patients. Cardiol J. 2009;16(2):142–145.
   PubMed Web of Science ®Google Scholar